Dov Klein sold $19k of FBIO
director at Fortress Biotech, Inc.. 10,000 shares at an average of $1.89, traded May 20, 2024, filed May 20, 2024.
Score components
- +15RoleDirector
- 0Trade size$19k at market
- +5Share of holdings soldSold 16% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -8.2%, 3m -0.5%, 6m -24.1%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-24-063451, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 20, 2024 | SOpen-market sale COMMON STOCK, PAR VALUE $0.001 | -10,000 | $1.89 | $19k | 53,400 | May 20, 2024 |
Related signals
Other insiders at Fortress Biotech, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 79Notable | FBIObuy Fortress Biotech, Inc. | Lindsay A Rosenwald Md PRESIDENT, CEO & CHAIRMAN | $1.4M 763,359 shares | +26% | |
| 52Moderate | Fortress Biotech, Inc. | Lindsay A Rosenwald Md President, CEO & Chairman | $37k 5,000 shares | +4% | |
| 46Moderate | Fortress Biotech, Inc. | David Jin Chief Financial Officer | $3,750 500 shares | - | |
| 52Moderate | Fortress Biotech, Inc. | Lindsay A Rosenwald Md President, CEO & Chairman | $37k 5,000 shares | +4% | |
| 52Moderate | Fortress Biotech, Inc. | Lindsay A Rosenwald Md President, CEO & Chairman | $37k 5,000 shares | +4% | |
| 47Moderate | Fortress Biotech, Inc. | Lindsay A Rosenwald Md President, CEO & Chairman | $33k 20,000 shares | +1% | |
| 28Weak | FBIObuy Fortress Biotech, Inc. | Lindsay A Rosenwald Md President, CEO & Chairman | $18k 10,000 shares | +0% | |
| 48Moderate | FBIObuy Fortress Biotech, Inc. | Lindsay A Rosenwald Md President, CEO & Chairman | $119k 50,000 shares | +2% | |
| 57Moderate | Fortress Biotech, Inc. | Michael S Weiss See Remarks | $250k 147,058 shares | +15% | |
| 86Strong | Fortress Biotech, Inc. | Lindsay A Rosenwald Md President, CEO & Chairman | $2.7M 1,567,515 shares | +152% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.